Clinical Trials Logo

Clinical Trial Summary

The aim of this study was to evaluated the advantages of routine application of the anterior approach in patients scheduled to right hepatectomy or extended right hepatectomy, without infiltration of segment 1, inferior vena cava or main bile duct.


Clinical Trial Description

Mobilization of the liver during right hepatectomy with classic approach is performed before parenchymal transection. In this phase severe bleeding may occur due to laceration of the inferior vena cava (IVC) wall, rupture or ligation falling off the hepatic short vein (HSV) or bleeding from the right liver attachments. Besides, the twisting of the portal pedicle during mobilization can render the left hepatic lobe ischemic for transient interruption of the hepatopetal flow. These events are more frequent in case of large hepatic lesions (mainly HCC) that involves surrounding structures (such as diaphragm). Two of the most important factors that affect the postoperative course of patients undergoing liver resections are indeed intraoperative bleeding and postoperative liver dysfunction. For these reasons Lai et al proposed anterior approach as alternative to classic right hepatectomy. In this case liver mobilization is performed only at the end of parenchymal transection, when all vascular connections are already interrupted. Liu et al published the results of a retrospective study in which 54 patients with, right sided HCC greater than 5 cm underwent right hepatectomy using the anterior approach technique. The anterior approach group had significantly less intraoperative blood loss, less need of blood transfusion and a lower hospital mortality rate. The same group reported results of a prospective randomized controlled study analyzing 120 patients with large (>5 cm) right liver HCC. The overall operative blood loss, morbidity, and duration of hospital stay were comparable in both groups. However, a higher number of patients in classic approach group experienced mayor operative blood loss (> 2000 cc) and required blood transfusions (8.3% vs. 28.3%). ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01180088
Study type Interventional
Source Azienda Ospedaliera Ordine Mauriziano di Torino
Contact
Status Not yet recruiting
Phase N/A
Start date August 2010
Completion date August 2011

See also
  Status Clinical Trial Phase
Completed NCT02557724 - Mobilization of Mesenchymal Stem Cells During Liver Transplantation
Terminated NCT04702230 - Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization
Active, not recruiting NCT01217034 - Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib Phase 2
Recruiting NCT05169177 - Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
Withdrawn NCT02599909 - Gut Microbiota in People With Hepatocellular Carcinoma (HCC)
Terminated NCT03998033 - Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma Phase 1
Recruiting NCT04010071 - Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors Phase 2
Recruiting NCT04864054 - T-Cell Therapy (ECT204) in Adults With Advanced HCC Phase 2
Terminated NCT04187937 - Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections N/A
Completed NCT02471313 - Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization Phase 2
Completed NCT00001576 - A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver Phase 1
Recruiting NCT01542281 - Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer N/A
Recruiting NCT03803436 - Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation Phase 2
Completed NCT05495529 - Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors
Recruiting NCT02632864 - Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial Phase 2
Completed NCT02571946 - Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis N/A
Withdrawn NCT00510627 - Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases Phase 4
Completed NCT05848947 - SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA Phase 4
Not yet recruiting NCT05723705 - Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT)
Terminated NCT04502082 - Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) Phase 1/Phase 2